Viking Therapeutics, Inc
XNAS:VKTX
36.33
$45.55 - 5.00
$36.50 - 10.00
$36.08
$36.83
$36.45
$36.27
54.54
18.92
1186797
3037873.5
109837759.42
Chart
TendieTensor AI Analysis
Company
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Fundamentals
51
-17.380000
5.805050
100
BBG006LGV869
BBG006LGV887
112.44M
113.04M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News